P-glycoprotein (Pgp) is a transmembrane protein of 170 kD encoded by the multidrug
resistance 1 (MDR-1) gene, localized on chromosome 7. More than 50 polymorphisms of the …

Leukocytapheresis (LCAP) long has been investigated with a leukocyte removal filter for the
treatment of various kinds of autoimmune related and inflammatory diseases such as …

Objectives. To evaluate the efficacy of filtration leucocytapheresis (LCP) for rheumatoid
arthritis (RA). Methods. LCP was carried out three times, with 1 week separating each …

Microparticles (MPs) are believed to play an important role in inflammatory diseases such as
rheumatoid arthritis (RA). Leukocytapheresis (LCAP) is one of the options available for the …

In this article, we discussed leukocytapheresis (LCAP) for rheumatoid arthritis (RA).
Recently, a simple and practical on-line continuous LACP system has been developed. It is …

An 18‐year‐old woman was treated with leukocytapheresis (LCAP) for her combined
ulcerative colitis (UC) and aortitis syndrome (AS). Because a close relationship between …

We treated 12 patients with rheumatoid arthritis by filtration leukocytapheresis (FLCP) and
evaluated its effect on leukocyte enzyme activities. We calculated the number of leukocytes …

Leukocytapheresis (LCAP) has recently been investigated for the treatment of drug‐resistant
rheumatoid arthritis (RA). In the present clinical study, we used LCAP in three patients with …

We evaluated the relationship between the clinical benefit of filtration leukocytapheresis
(LCP) and the number of removed leukocytes in patients with rheumatoid arthritis (RA). LCP …

Both monocyte-granulocytapheresis (M-GCAP) and leukocytapheresis (LCAP) are
categorized as extracorporeal leukocyte removal therapies (ECCTs). These therapies have …